Luts & Greenleigh Group’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.45M Sell
14,133
-260
-2% -$29.4K 1.15% 19
2025
Q4
$1.8M Sell
14,393
-142
-1% -$18.1K 1.53% 12
2025
Q3
$1.95M Sell
14,535
-119
-0.8% -$15.6K 1.75% 10
2025
Q2
$1.99M Sell
14,654
-31
-0.2% -$4.09K 1.91% 9
2025
Q1
$1.95M Buy
14,685
+254
+2% +$32.3K 1.94% 7
2024
Q4
$1.63M Sell
14,431
-8
-0.1% -$924 1.61% 11
2024
Q3
$1.65M Buy
14,439
+222
+2% +$24.4K 1.58% 11
2024
Q2
$1.48M Buy
+14,217
New +$1.51M 1.54% 12
2023
Q4
$1.52M Sell
13,765
-244
-2% -$24.4K 1.91% 9
2023
Q3
$1.36M Sell
14,009
-92
-0.7% -$9.66K 1.68% 10
2023
Q2
$1.54M Buy
14,101
+4
+0% +$426 1.9% 8
2023
Q1
$1.43M Buy
14,097
+133
+1% +$14K 1.81% 9
2022
Q4
$1.53M Buy
+13,964
New +$1.45M 1.94% 9

Other funds holding ABT

Luts & Greenleigh Group's ABT Position: Q1 2026 in Review

Luts & Greenleigh Group reduced its Abbott (ABT) stake by 1.8% in Q1 2026, selling an estimated $29.4K and leaving 14,133 shares worth $1.45M. The position accounts for 1.15% of the portfolio, ranked #19.

Luts & Greenleigh Group first reported a position in ABT in Q4 2022 and has held it in 13 quarters since. The position peaked at $1.99M in Q2 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Luts & Greenleigh Group held 14,133 shares of Abbott worth $1.45M as of Q1 2026.
  • Luts & Greenleigh Group sold 260 Abbott shares in Q1 2026, an estimated $29.4K.
  • Abbott made up 1.15% of Luts & Greenleigh Group's portfolio in Q1 2026, its #19 holding.
  • Luts & Greenleigh Group first reported a position in Abbott in Q4 2022 and has held it in 13 quarters since.
  • Luts & Greenleigh Group's Abbott position peaked at $1.99M in Q2 2025.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Luts & Greenleigh Group's 13F filing for Q1 2026, filed 5 May 2026.